Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Other Accumulated Expenses: 2014-2025

Historic Other Accumulated Expenses for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $238.5 million.

  • Surgery Partners' Other Accumulated Expenses fell 152.77% to $238.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $238.5 million, marking a year-over-year decrease of 152.77%. This contributed to the annual value of $253.9 million for FY2024, which is 2439.98% up from last year.
  • Latest data reveals that Surgery Partners reported Other Accumulated Expenses of $238.5 million as of Q3 2025, which was down 152.77% from $229.1 million recorded in Q2 2025.
  • Surgery Partners' Other Accumulated Expenses' 5-year high stood at $291.8 million during Q3 2022, with a 5-year trough of $198.1 million in Q2 2023.
  • In the last 5 years, Surgery Partners' Other Accumulated Expenses had a median value of $221.1 million in 2022 and averaged $223.0 million.
  • In the last 5 years, Surgery Partners' Other Accumulated Expenses surged by 4008.64% in 2022 and then crashed by 2864.98% in 2023.
  • Over the past 5 years, Surgery Partners' Other Accumulated Expenses (Quarter) stood at $210.0 million in 2021, then grew by 0.05% to $210.1 million in 2022, then fell by 2.86% to $204.1 million in 2023, then increased by 24.4% to $253.9 million in 2024, then dropped by 6.07% to $238.5 million in 2025.
  • Its Other Accumulated Expenses stands at $238.5 million for Q3 2025, versus $229.1 million for Q2 2025 and $233.5 million for Q1 2025.